| Ytd | -50.41% | |
| 1y | -50.41% |
| Open | 3.70 | Prev Close | 3.56 | Low | 3.62 | High | 3.70 | Mkt Cap | 23.15M |
| Vol | 20.75K | Avg Vol | 1.43M | EPS | -0.84 | P/E | -4.24 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.33 | 200-d Avg | 4.41 | 1yr Est | 0.00 |
PLSM News
Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-marke
The program is designed to enable Pulsenmore to develop and clinically validate AI applications that
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund it
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg
U.S. stocks rise with Dow gaining over 400 points. Energy stocks fall while healthcare shares surge.
US stocks higher, Nasdaq up 100 pts. Dow up 0.07%, Nasdaq up 0.52%, S&P 500 up 0.45%. Consumer d
PLSM stock surges over 200% premarket as Pulsenmore partners with Ouma Health to bring FDA-authorize
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
Through the collaboration, Ouma Health will incorporate Pulsenmore's FDA-authorized home ultraso
